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Slide 2. Problem Identification
• Sharp increase in HAV in 2020 in Maine compared to previous years
• 39 cases in first half of 2020 compared to 7-10 cases per year
• 2019 also had a large increase in cases – 45 cases total

• At least 21 cases in 2020 had risk factors of injection drug use or
housing insecurity
• During my time at Central Maine Medical Center Family Medicine
Residency in Lewiston, ME, saw many patients with housing
insecurity – and therefore could benefit from HAV prevention

Slide 3. Public Health Costs
• In 2018, 1/3 of those that contracted HAV in Maine were hospitalized

• Unable to find data on exact costs in Maine with regards to recent
outbreak

Slide 4. Community perspective and support
for project
• Kara Callahan, MD (preceptor) and several family medicine residents
• Residents said that they were unaware of the HAV outbreak in recent
years
• Residents expressed that they were unsure of the indications for HAV
vaccination

• One resident explained that it would be helpful to have a smart phrase for
patient education
• Dr. Callahan provided information of clinic pharmacist, who did not respond
to request for input

Slide 5. Intervention & Methodology
• Creation of printable, easy-to-read HAV information sheet for
providers with list of groups in which the vaccine is recommended
• Creation of editable “dot phrase”/smart phrase for providers to edit
and implement as they see fit
• Sent info sheet and dot phrase to preceptor to disburse to providers
• Plan to present these resources at resident didactics session

Slide 6. Results
• “Dot phrase” as below:
• .HAVedu:
• You have received _1 out of three of the vaccines to
protect against Hepatitis A. You will return in _1 month
for the next vaccine. Completing all three vaccines will
protect you from Hepatitis A, a disease of the liver. You
may have an increased chance of getting the disease or
are more likely to have serious complications from it.
The most common side effects from the vaccine are
tiredness, headache, decreased appetite, and
redness/swelling/pain around the injection site. Please
ask your doctor any questions about the vaccine or
about hepatitis.

Slide 7. Evaluation of effectiveness and
limitations
• Evaluation of effectiveness may be assessed by rates of provider
prescription of HAV vaccination after presentation of information
and printing of info sheet around the clinic
• Limitations include provider buy-in and implementation of routine
HAV vaccination for adults

Slide 8. Recommendations for future
interventions/projects
• Potential future interventions could include
• Outreach to known housing-insecure patients to encourage immunizations
• Include HAV vaccination when screening for other liver diseases such as
Hepatitis C, autoimmune hepatitis, or evaluating for alcoholic liver disease
• Ask parents of children receiving HAV vaccine at well child visit if they are also
interested in receiving the vaccine
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